VitaNova Life Sciences (VNOV) Return on Capital Employed (2019 - 2026)
VitaNova Life Sciences (VNOV) posted Return on Capital Employed of 64.08% for Q1 2026, down 5.69% on a QoQ basis from 67.95% in Q4 2025, and up 3077.0% year-over-year from 2.02% in Q1 2025.
VitaNova Life Sciences (VNOV) Return on Capital Employed (2019 - 2026) Analysis & Trends
VitaNova Life Sciences' Return on Capital Employed history runs 6 years deep, the most recent figure standing at 64.08% for Q1 2026.
- Quarterly Return on Capital Employed rose 3077.0% year-over-year to 64.08% in Q1 2026, while the trailing twelve-month figure through Jan 2026 was 64.08% (up 3077.0% YoY) and the FY2025 annual result came in at 87.75%, up 4342.0% from the prior year.
- Return on Capital Employed was 64.08% for Q1 2026 at VitaNova Life Sciences, down from 67.95% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 310.01% in Q1 2022 and bottomed at 12.04% in Q4 2022.
- A 5-year average of 74.79% and a median of 64.71% in 2025 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed sank 22143 bps — and 2025, when it jumped 6201 bps.
- VitaNova Life Sciences' Return on Capital Employed stood at 12.04% in 2022, then jumped by 321 bps to 26.59% in 2023, then slipped by 4 bps to 25.43% in 2024, then soared by 167 bps to 67.95% in 2025, then decreased by 6 bps to 64.08% in 2026.
- Business Quant data shows VNOV's Return on Capital Employed at 64.08% in Q1 2026, 67.95% in Q4 2025, and 65.33% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.52 Bn | 101.55 Bn | 4.04 Bn | 38.25% |
| 2 | Cencora | 60.84 Bn | 58.66 Bn | 3.59 Bn | 11.68% |
| 3 | Cardinal Health | 53.88 Bn | 49.95 Bn | 2.50 Bn | 15.02% |
| 4 | Henry Schein | 9.80 Bn | 9.67 Bn | 1.07 Bn | 8.29% |
| 5 | Akso Health | 3.06 Bn | 3.06 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | -0.62% |
| 7 | Accendra Health | 246.88 Mn | -90.00 Mn | 278.03 Mn | 2.01% |
| 8 | Edap Tms | 228.64 Mn | 213.64 Mn | 8.15 Mn | -67.59% |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | 64.08% |
| 10 | Cosmos Health | 9.34 Mn | 7.18 Mn | 1.38 Mn | -60.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 64.08% |
| Oct 31, 2025 | 67.95% |
| Jul 31, 2025 | 65.33% |
| Apr 30, 2025 | 83.84% |
| Jan 31, 2025 | 33.30% |
| Oct 31, 2024 | 25.43% |
| Jul 31, 2024 | 18.49% |
| Apr 30, 2024 | 21.84% |
| Apr 30, 2023 | 26.59% |
| Jan 31, 2023 | 88.58% |
| Oct 31, 2022 | -12.04% |
| Jul 31, 2022 | 83.99% |
| Apr 30, 2022 | 169.64% |
| Jan 31, 2022 | 310.01% |
| Jan 31, 2019 | 123.43% |